Quantcast
Last updated on April 21, 2014 at 12:45 EDT

Latest Juvenile Dermatomyositis Stories

2012-09-13 02:26:49

ANAHEIM, Calif., Sept. 13, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that the company will be teaming up with The Myositis Association (TMA) to support research and educational initiatives in dermatomyositis and polymyositis. "Questcor is very pleased to be able to make this commitment to The Myositis Association and the dermatomyositis and polymyositis communities," said Steve Cartt, Chief Operating Officer of Questcor. "Further research into these...

2006-03-22 15:59:59

NEW YORK (Reuters Health) - Prompt diagnosis and treatment of dermatomyositis (JDM) in children is important, researchers report. Dermatomyositis is a rare inflammatory disorder in which the immune system attacks muscle and skin, often causing an extensive rash, as well as progressive, severe muscle weakness, pain, and fatigue. Dr. Lauren M. Pachman, of Northwestern University, Chicago, and colleagues examined the effect of the duration of untreated symptoms in 166 children. The...